ClinicalTrials.Veeva

Menu

Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

T

Turku University Hospital (TYKS)

Status

Withdrawn

Conditions

Ulcerative Colitis

Treatments

Other: Fecal microbiota transplantation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to find out whether a single fecal microbiota transplantation is an effective and safe treatment as an adjunct to standard therapy in patients with ulcerative colitis.

Sex

All

Ages

1 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • active ulcerative colitis (PUCAI 10-64) in whom fecal microbiota transplantation via colonoscope can be performed

Exclusion criteria

  • severe ulcerative colitis (PUCAI > 65)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Fecal microbiota transplantation
Active Comparator group
Description:
A single fecal microbiota transplantation via colonoscope as an adjunct therapy to standard medical treatment
Treatment:
Other: Fecal microbiota transplantation
Standard medical treatment
No Intervention group
Description:
Standard medical treatment as recommended by the ECCO Guidelines of UC therapy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems